Влияние реперфузионной терапии и клеточной кардиомиопластики на структурно-функциональные изменения сердца, клиническое течение и отдаленные исходы у больных острым первичным трансмуральным передним и
Диссертация
Всероссийском научном форуме с международным участием «Молекулярные основы иммунорегуляции, иммунодиагностики и иммунотерапии» (Санкт-Петербург, 2006) — Всероссийской и международной конференции «Стволовые клетки и перспективы их использования в здравоохранении» (Москва, 2006) — Российской конференции «Новые технологии повышения эффективности вмешательств в кардиологии и-кардиохирургии» (Москва… Читать ещё >
Список литературы
- Адамян К.Г., Чарчоглян P.A. Особенности развития сердечной недостаточности при остром инфаркте миокарда и возможности ее коррекции. Кардиология 1988- 4: 31−34.
- Алехин М.Н. Тканевой допплер в клинической эхографии. М.- 2006- 104.
- Алехин М.Н., Ахунова С. Ю., Рафиков А. Ю. Воспроизводимость измерений скоростей движения миокарда левого желудочка в режиме тканевого допплера. Ультразвуковая и функциональная диагностика 2004- 2: 9299.
- Алехин М.Н., Ахунова С. Ю., Рафиков А. Ю. Воспроизводимость измерений скоростей движения фиброзного кольца митрального клапана в режиме тканевого допплера. Ультразвуковая и функциональная диагностика 2005- 1: 105−111.
- Алперт Дж., Френсис Г. Лечение инфаркта миокарда. Практическое руководство: Пер. с англ. М.: Практика, 1994- 255.
- Арбалинский A.B., Роган C.B., Сидельников A.B. Стентирование коронарных артерий в клинической практике. Кардиология 2000- 9: 100−105.
- Арутюнов Г. П., Розанов A.B., Степанова Л. В. и др. Влияние тромболи-тической терапии на динамику недостаточности кровообращения и процессы ремоделирования миокарда левого желудочка. Кардиология 2001- 3: 13−16.
- Ахмедов Ш. Д., Кривощеков Е. В., Пекарская М. В. и др. Отдаленные клинические результаты кардиомиопластики. Кардиология 1996- 6: 74−77.
- Барбакарь ИТ., Мазаев A.B. Клиническая эффективность, и: методика применения стрептодеказы. у больных- острым инфарктом, миокарда. Тер. архив 1984- 11: 19−23.
- Беленков Ю.Н. Неинвазивныс методы диагностики ишемической болезни сердца. Кардиология 1996- 1:4−11.
- Беленков Ю. Н: Ремоделирование: левого желудочка: комплексный подход. Сердечная недостаточность 2004- 4: 161−164.
- Беленков Ю.Н., Атьков О. Ю., Ню-тян-де Г.Б. Изучение сегментарной функции левого желудочка у больных ишемической болезнью: сердцах помощью ультразвуковых методик. Кардиология 1979- 9: 28−31.
- Беленков Ю.Н., Мареев В. Ю., Арутюнов Г. П., Агеев Ф. Т. Национальные рекомендации по диагностике и лечению хронической сердечной недостаточности. Сердечная недостаточность 2003- 4 (6): 57 76.
- Беленков Ю. Н-, Мареев В. Ю., Орлова Я. А., Флоря В. Г., Синицин В. Е. Магнитно-резонансная- томография- в оценке ремоделирования левого желудочка у больных с сердечной недостаточностью- Кардиология 1996- 4: 15−22.
- Белов A.A., Данилогорская Ю. А., Лакшин A.A. Основные методы функциональной диагностики в клинике внутренних болезней. М.: Издательский дом «Русский врач» 2003- 106.
- Белов Ю.В., Вараксин В. А. Постинфарктное ремоделирование левого желудочка сердца. От концепции к хирургическому лечению. М.: ДеНо-во, 2002- 194.
- Белоусов Ю.Б., Чучалин А. Г. Насонов Е.В., Агеев Ф. Т. Роль воспаления в клинике внутренних болезней. Проблемы и перспективы РМЖ, 2001- № 12: 70−90.
- Белоусов Ю.Б., Чучалин А. Г., Насонов Е. Л., Мареев В. Ю., Агеев Ф. Т. Роль воспаления в клинике внутренних болезней. Проблемы и, перспективы. РМЖ 2001- 9 (12): 487 503.
- Берштейн Л.Л. Тканевое допплеровское исследование и его применение у пациентов с ишемической болезнью. Российский кардиологический журнал. 2006- 6: 93−100.
- Бокарев И.Н., Довголис С. А. Тромболитическая терапия инфаркта миокарда. РМЖ 1998- 6 (3): 23 36.
- Бокерия Л.А., Бузиашвили Ю. И., Макцеплишвили С. Т. и др. Первый опыт применения стволовых клеток костного мозга для регенерацион-ной терапии ишемической болезни сердца. Кардиология 2004- № 9: 1622.
- Бочков Н.П. Клеточная терапия в свете доказательной медицины. Клиническая медицина 2006- № 10: 4−10.
- Братчик A.M. Клинические проблемы фибринолиза. К., 1993- 342.
- Браунвальд Е., Росс Дж., Зонненблик Е. Х. Механизмы сокращения в> норме и при недостаточности. Пер. с англ. М.: Медицина 1974- 174.
- Варваренко В.И., Марков В. А., Кун В.И. и др. Изменение сократительной функции левого желудочка под влиянием тромболитической репер-фузии коронарных артерий при остром инфаркте миокарда. Кардиология 1990- 10: 12−15.
- Васильев Н.В. Наука и общество в XXI веке. Сибирский медицинский журнал 2008- 3:5−12.
- Васюк Ю.А. Возможности и ограничения эхокардиографического исследования вюценке ремоделирования левого желудочка, при ХСН. Сердечная недостаточность 2003- 2: 107−110.
- Васюк Ю.А., Копелева М. В., Хадзегова А. Б., Сергеев B.C. Диагностиче-, ские возможности стресс-ЭхоКГ с использованием тканевой допплеро-графии. Сердечная недостаточность 2004−6: 303−307.
- Венгеровский А.И. Лекции по фармакологии для врачей и провизоров. Томск: STT, 2001- 476.
- Вермель А.Е. Стволовые клетки: общая характеристика и перспективы применения в клинической практике. Клиническая медицина 2004- 1: 511.
- Воскобой В.И., Ребров А. П. Влияние антиагрегантов на концентрацию цитокинов плазмы крови у больных острым коронарным синдромом. Клиническая медицина 2003- 6: 23 27.
- Канюков В: И. Диагностика и лечение инфаркта, миокарда с элевацией сегмента ST. Рекомендации АСС/АНА. Новосибирск: ИПЦ «Юпитер» 2006-, 12 114-
- Гватуа Н.А., Вайсман С. Г. Иммунологические сдвиги при инфаркте миокарда. Кардиология 1973- 11: 140−148.
- Гендлин Г. Е., Самсонова. Е.В., Бухало О. В., СторожаковГ.И.Методики. исследования качества жизни- у больных хронической недостаточностью-1 кровообращения. Сердечная недостаточность 2000- 1 (2): 44 54.
- Еитель Е. Ш, Тусев Д-Е., Пономарь Е. Г., Роль интерлейкинов- в патогенезе атеросклероза. Клиническая медицина 2006- 6: 10 15.
- Голиков А.П., Зверева1 Т.В. Ближайшие и отдалённые результаты тром-болитической терапии у больных инфарктом миокарда: необходимость дифференцированного лечения: Кардиология 1992- 4: 5−7.
- Гольдберг Е. Д-, Дыгай A.M., Жданов В. В: Современные взгляды на проблему использования стволовых клеток и возможности их использования в медицине. Клеточные технологии в биологии и медицине 2005- 4: 184−189.
- Дзизинский A.A., Гомазков O.A. Кинины в физиологии и патологии сердечно-сосудистой системы. Новосибирск. 1976- 206.
- Дудко В.А., Карпов P.C. Атеросклероз сосудов сердца и головного мозга. Томск: STT 2003- 416.
- Егоренкова Л.В., Баранов А. П., Бузин А. Г., Корсунская И. М. Оценка ци-токинового ответа у пациентов с ишемической болезнью сердца, псориазом и их сочетанием. Российский кардиологический журнал 2005- 2 (52): 83 87.
- Жиронкина Н.П., Олейникова Е. А. Нейроиммунные эффекты интерлей-кинов. Международный медицинский журнал 1999- 1: 144−146.
- Заволожин С.А., Миролюбова O.A., Голышев C.B., Заволожин A.C. Влияние отсроченной коронарной ангиопластики после тромболитиче-ской -терапии на исход острого инфаркта миокарда. Кардиология 2006- 10: 8−12.
- Закирова А.Н., Мухаметрахимова А. Р., Закирова Н. Э. Состояние систолической функции левого желудочка и активность провоспалительных цитокинов при остром инфаркте миокарда. Сердечная недостаточность 2005- 4: 162−165.
- Казаков A.B., Мюллер П., Бельтрами А. П. и соавт. Стволовые клетки и регенерация миокарда человека. Кардиология 2005- 11: 65 75.
- Карпов P.C. (ред.) Коронарная и сердечная недостаточность. Томск: STT 2005- 716.
- Карпов P.C. (ред.) Тромболитическая терапия острого инфаркта миокарда на догоспитальном этапе: методика, эффективность, защита миокарда. Методические рекомендации. Томск: 1999- 34.
- Карпов P.C., Дудко* В.А. Атеросклероз: патогенез, клиника, функциональная диагностика, лечение. Томск: SST, 1998: 656 с.
- Карпов PIG., Марков В. А., Даниленко A.M. и-др. Эффективность тром-болитической терапии острого инфаркта миокарда на догоспитальном этапе. Кардиология 1992−9 (10): 23−26.
- Козлов В.А. (ред.), Сенников С. В. (ред.) Система*цитокинов: Теоретические и клинические аспекты. Новосибирск: «Наука» 2004- 324.
- Козлов В.А. Внутриклеточные факторы регуляции активности стволовых, кроветворных клеток. Клеточные технологии в биологии и медицине 2005- 1:4−12'.
- Корочкин И.М., Чукаева И. И., Орлова Н. В. и др. Маркеры воспалительного ответа и размеры инфаркта миокарда. Кардиология 1993- 1: 46−47.
- Кремнева- Л.В., Абатурова О. В. Молекулярно-клеточные механизмы ремоделирования миокарда при. сердечной недостаточности. Клиническая медицина 2003- 2: 4 -7.
- Крыжановский В.А. Диагностика и лечение инфаркта миокарда: Киев: Феникс, 2001,451 с.
- Лишманов Ю.Б., Веснина Ж.В, Рыбальченко Е. В-, Крылов А.-Л. Применение перфузионной сцинтиграфии миокарда для оценки результатов эндоваскулярного лечения ишемической болезни сердца. Медицинская радиология и радиационная: безопасность 2004- 4: 45−53.
- Лишманов Ю.Б., Чернов. В. И. Сцинтиграфия миокарда в ядерной карг диологии. Томск: Изд. ТГУ 1997, 276-
- Люсов В.А. Кардиология (под редакцией Оганова Р. Г., Фоминой И.Г.) Москва, «Медицина», 2004, С.397−474.
- Лякишев А.А. Сравнение эффективности имплантации голых металлических стентов и стентов, покрытых препаратом сиролимус, для лечения больных с острым инфарктом миокарда. Кардиология 2006- 11: 73.
- Мазуров В.И., Столов С. В., Зарайский- М.И. Иммунологические механизмы в патогенезе коронарного атеросклероза. Тер. архив 2005- 9: 24 -28., • ¦
- Макаридзе О. В- Значение показателей функционального состояния сердца по данным эхокардиографии и велоэргометрии в постинфарктном периоде для отдаленного прогноза. Кардиология 1986- 11: 67−70.
- Малая Л.Т., Власенко М.А, Микляев И. Ю. Инфаркт миокарда. М.: Медицина 1981, 111с.
- Мареев В.Ю. Разгрузочная терапии у больных, перенесших острый инфаркт миокарда. СопвШит тесИсит 2000- 2(11): 477−494.
- Мареев В. Ю, Беленков Ю. Н. Перспективы в лечении хронической сер-: дечной недостаточности. Сердечная недостаточность 2003- 3: 109−114.
- Марков В. А., Варваренко В. И., Кун В.И. и др. Сравнение внутри коронарного и внутривенного1 методов тромболитической терапии стрептокиназой больных острым инфарктом миокарда. Кардиология 1988- 5: 2023.
- Марков В.А., Вышлов Е. В., Панфилова Е. В. и др. Сравнение эффективности стрептокиназы при болюсном и капельном введении у больных инфарктом миокарда. Кардиология 2002, 9, С. 26−29.
- Маркарян С.С., Елизарова H.A. Гемодинамика правых отделова сердца у больных перенесших инфаркт миокарда левого желудочка. Кардиолог-гия 1989- 3: 89−90.
- Марков В.А., Максимов И. В., Варваренко В. И., Джавадов К. Ю. ЭКГ-критерии реперфузии миокарда при внутривенном быстром введении нативной стрептокиназы у больных инфарктом миокарда. Актуальные вопросы кардиологии, Томск 1994- 8: 85−89.
- Марри Р., Греннер Д., Мейес П., Родуэлл В'. Биохимия человека: В 2 т. Т.2.: Пер. с анг. М.: Мир 2004- 330.
- Маянский Д. Н, Цырендоржиев Д. Д., Маянский С. Д. Лейкоцит-модулирующая активность сыворотки при остром- коронарном синдроме. Сиб. мед. Журнал 1998- 13(1−2): 19−21.
- Меерсон Ф. 3. Патогенез и предупреждение стрессовых и ишемических повреждений сердца. М., 1984- 122.
- Меерсон Ф.З. Адаптационная медицина: концепция долговременной адаптации. Москва «Дело» 1993- 138.
- Меерсон Ф.З. Адаптация, дезадаптация и недостаточность сердца. М. 1978- 343.
- Миррахимов М.М., Болтабаев Т. Б., Цой Н.Л. Клинический опыт применения стрептодеказы на догоспитальном этапе лечения острого инфаркта миокарда. Кардиология 1987- 2: 21−24.
- Насонов Е.Л., Самсонов М. Ю. Новые аспекты патогенеза сердечной недостаточности: роль, фактора некроза опухоли. Сердечная недостаточность 2001- 1 (4): 139- 143.
- Насонов Е.Л., Самсонов>М.Ю., Беленков Ю. Н., Фукс Д. Иммунопатология застойной сердечной недостаточности: роль цитокинов. Кардиология 1999- 66−73.
- Недоступ A.B., Благова О. В. Как лечить аритмии. Диагностика и терапия нарушений ритма и проводимости в клинической практике. М.: МЕД-пресс-информ 2006- 288.
- Никитин Н.П., Аляви А. Л., Голоскокова В. Ю., Маджитов Х. Х. Особенности процесса позднего5 ремоделирования сердца у больных, перенесших инфаркт миокарда и их прогностическое значение. Кардиология 1999- 1: 54−58.
- Никитин Н.П., Клиланд Д.Д. Ф. Применение тканевой миокардиальной допплерэхокардиографии в кардиологии. Кардиология 2002- 3: 66−79.
- Нормальное кроветворение и его • регуляция. Под ред. академика АМН СССР проф. Федорова, М. Медицина 1976- 543.
- Оганов P. F, Фомина И. Г. Кардиология: Руководство для врачей. М.: Медицина, 2004- 848.
- Оганов Р.Г., Масленникова Г. Я. Профилактика сердечно-сосудистых заболеваний реальный путь улучшения демографической ситуации в России. Кардиология 2007- 1: 4−7.
- Орлов Л.Л., Шилов A.M., Ройтберг Г. Е. Сократительная функция и ишемия миокарда. М.: Наука 1987- 247.
- Останин A.A., Черных Е. Р. Сравнительная оценка уровня 17 цитокинов в сыворотке и цельной крови здоровых доноров методом проточной флюорометрии. Цитокины и воспаление 2005- 2: 25−32.
- Павлюкова E.H., Шмырин A.B., Дамбаев А. И. и др. Сегментарная систолическая и диастолическая функции левого желудочка у практически здоровых лиц. Ультразвуковая и функциональная диагностика 2002- 3: 71−76.
- Палеев Н.Р., Палеев Ф. Н. Цитокины и их роль в патогенезе заболеваний сердца. Клиническая медицина 2004- 5: 4 7.418
- Пауков B.C. Роль нейтрофилов и макрофагов в локализации гноероднойинфекции. Архив патологии!986- Вып. 3: 30 38.
- Перепеч Н.Б. Полная нейрогуморальная блокада что дальше?. Сердечная недостаточность 2001- 2 (2): 74−82.
- Починка И.Г., Стронгин Л. Г., Чары ко ва И.Н. Уровень фактора некроза опухоли у больных в подострую стадию инфаркта: миокарда. Сборник тезисов Российского национального конгресса кардиологов, 8−11.10.02, Санкт-Петербург: 332.
- Рафиков А. 10., Галявич А. С. Взаимосвязь скорости движения миокарда левого желудочка и частоты сердечных сокращений по данным тканевого допплера. Российский национальный конгресс кардиологов: тез. докладов. Санкт-Петербург 2002- 339.
- Рахмат-Заде Т.М., Скридлевская Е. А., Акчурин P.C. Костномозговые стволовые клетки в лечении* ишемической болезни сердца. Кардиология 2007- 1:47−51.
- Ш. Репин B.C. Стволовые клетки и старение: идеи и реальность. Клин, геронтология 2001- 12: 29 36.
- Репин B.C. Эмбриональная стволовая клетка: от фундаментальных исследований в клинику. Пат. физиол. и экспер. терапия12 002- 2: 3 — 8.
- Репин B.C., Сухих Г. Т. Медицинская клеточная биология. Ml, РАМН: БЭБиМ 1998- 200.
- Руда М.Я. О системе лечения больных с острым коронарным синдромом. Кардиологический вестник 2006- 2 (XIII): 5−9.
- Руда М.Я., Зыско А. П. Инфаркт миокарда. М., Медицина, 1981, 288 с.
- Руководство по гематологии: В 2 т. Т.1. Под редакцией А. И. Воробьева. М.: Медицина, 1985, 448.
- Руксин В.В. Тромбозы в кардиологической практике. СПб.: Невский диалект, М.: Бином, 1998- 126.
- Румянцев П.П. Кардиомиоциты в процессах репродукции, дифференци-ровки и регенерации. JL: Наука, 1982- 288.
- Саркисов Д.С. Регенерация и ее клиническое значение. М., Медицина, 1979- 284.
- Саркисов Д.С. Регенерация и ее клиническое значение. М., Медицина, 1979−284.
- Сергеев B.C. К вопросу об иммуногенности эмбриональных стволовых клеток человека и их коммутированных производных. Клеточная трансплантология и тканевая инженерия 2006- 1 (3):22 23.
- Сидоренко Б.А., Преображенский Д. В. Лечение и профилактика хронической сердечной недостаточности. М.: ЗАО «ПРЕСИД», 1997- 192.
- Система цитокинов: теоретические и клинические аспекты. Под.ред. В. А. Козлова, С. В. Сенникова. Новосибирск: Наука, 2004, 324.
- Смирнов A.A. Косвенные признаки коронарной реперфузии у больных инфарктом миокарда. Бюлл. ВКНЦ АМН СССР, 1988−1: 112−113.
- Смолянинов А.Б., Лобзин Ю. В., Васильев В. Б., Козлов К. Л., Кириллов Д. А. Стволовые клетки в клеточной кардиомиопластике при ишемической болезни сердца. Трансфузиология 2006- 2: 4 38.
- Староверов И.И., Коткин К. Л. Пуролаза отечественный тромболитиче-ский препарат третьего поколения. Использование при остром инфаркте миокарда. Русский медицинский журнал 2004- 12(9):3−7.
- Сухих Г. Т., Малайцев В. В., Богданова И. М., Дубровина И. В. Мезенхи-мальные стволовые клетки. Бюлл. экспер. биол. и мед. 2002- 133 (2): 124 131.
- Сыркин А.Л. Инфаркт миокарда. 2-е изд., перераб. и доп. М.: ООО «Медицинское информационное агентство», 1998- 398.
- Терещенко С.Н., Джаниани H.A. Хроническая сердечная недостаточность. Вопросы диагностики и лечения. Методические рекомендации. М.: РКИ Северопресс, 2004- 48.
- Терещенко С.Н., Жиров И1В. Место бета-блокаторов в лечении больных, перенесших инфаркт миокарда. Кардиология 2006- 12: 73 77.
- Трифонов И.Р. Биохимические маркеры некроза миокарда. Часть I. Общая характеристика биомаркеров. Их применение для диагностики инфаркта миокарда: обзор современных рекомендаций. Кардиология 2001- 11:93−98.
- Трифонов И.Р. Сравнение реперфузионной терапии тенектеплазой и прямого чрескожного коронарного вмешательства у рано госпитализированных больных с острым инфарктом миокарда. Результаты исследования WEST. Кардиология 2006- 11: 76 77.
- Тромболитическая терапия острого инфаркта миокарда на догоспитальном этапе: методика, эффективность, защита миокарда. Методические рекомендации под редакцией академика РАМН P.C. Карпова. Томск, 1999- 34.
- Фейгенбаум X. Эхокардиография. Пер. с англ. под ред. Митькова В. В. М: Видар, 1999- 512.
- Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М.: Медиасфера, 1998- 352.
- Ходос Б.А., Гиринчир В. К., Скибицкий В. В. Возможности новой технологии доплеровской визуализации тканей в диагностике скрытой коронарной недостаточности. Кардиология'1996- 9:55−58.
- Чазов Е.В., Матвеева U.C., Мазаев A.B. и соавт. Внутрикоронарное на-' значение фибринолизина при остром инфаркте миокарда. Тер. Архив 1976- 48 (4): 8.
- Чертков И.Л., Дризе Н. И. Пластичность костно-мозговых стволовых клеток. Терапевртический архив 2004- 7: 5−11.
- Чумакова Г. А., Киселева Е. В., Алешкевич В. В., Чурсина В. И. Выбор оптимальной интенсивности тренировок у больных и инфарктом миокарда и артериальной гипертонией. Сердечная недостаточность 2002- 5: 215 217.
- Чупикова Н.И., Ростовская М. С., Шарифуллина С. З., Тепляшин A.C. Выделение мезенхимальных стволовых клеток костного мозга человека и их характеристика. Цитология 2004- 46(10): 947−948.
- Шахов В.П., Попов C.B. Стволовые клетки и кардиомиогенез в норме и патологии. Томск: STT, 2004- 170.
- Шахов В.П., Попов C.B., Афанасьев C.B. Пластический потенциал мезенхимальных стволовых клеток костного мозга для лечения заболеваний, связанных с повреждением сердечной ткани. Кардиология 2005- № 2: 45−46.
- Шевченко Ю.Л., Матвеев G.A. Клеточные технологии в сердечнососудистой хирургии. М: Медицина- 2005- 160 с.
- Шиллер IT., Осипов М. А. Клиническая эхокардиография. М.: Практика, 1993- 347.146: 1Шант Р: К., Александер Р-В7- Клиническая кардиология. Пер. с англ. М.: СПб.- 2000- 576.
- Явелов И.С. Проблемы тромболизиса в начале XXI века. Сердечная недостаточность 2007- 4:184−189.
- Abbate A%, Bussani R., Giuseppe G.E.Вiondi-Zoccai et all: Infarct-related'artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. European Heart Journal 2005- 26: 2039−2045
- Akhras F, Ousa AA, Swan G. et al. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a new cardiac unit. J Am Coll Cardiol 1997- 29: A235-A236.
- Alkjaersig N, A. Fletcher, S. Sherry et al. The mechanism of clot dissolution by plasmin. J. Clin. Invest. 1959- 38: 1086−1095.
- Alpert J., Thygesen K. Myocardial Infarction Redefined. J Am Coll Cardiol 2000- 36:959−969.
- Alter DA, Tu JV, Austin PC, Naylor CD. Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada. J Am Coll Cardiol 2003- 42: 410−419.
- Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003- 425: 968−973.
- Andersen HR, Nielsen TT, RasmussenK. et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003- 349: 733−742.
- Anderson J.L., Sorensen S.G., Moreno F.L. et al. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocadial infarction. Circulation 1991- 83: 126−40.
- Anguenot T., Bassand J.P., Bernard Y., Schiele F. Left ventricular remodeling after myocardial infarction Abstract. Arch. Mai. Coeur. Vaiss. 1992- 85(5): 781−787.
- Antonio C, Ferby I, Wilhelm H, et al. X kid, a chromokinesin required for chromosome alignment on the metaphase plate. Cell 2000- 102: 425 — 435.
- Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998- Vol.83(l): 1−14.
- Anversa P, Nadal-Ginard B. Cardiac chimerism: methods matter. Circulation 2002- 106: el29 el31.
- Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002- 415: 240 243.
- Anversa P, Olivetti G, Meggs LG, Sonnenblick EH, Capasso JM. Cardiac anatomy and ventricular loading after myocardial infarction. Circulation (suppl VII) 1983- 87: 22 27.
- Anversa P, Olivetti G. Cellular basis of physiological and pathological myocardial growth. In: Page E, Fozzard H, Solaro RJ, eds. Handbook of Physiology. The Cardiovascular System: The Heart. New York, NY: Oxford University Press- 2002: 75 144.
- Anversa P. Myocyte death in the pathological heart. Circ Res. 2000- 86: 121— 124.
- Anversa P., Beghi C., Kikkawa Y., Olivetti G. Myocardial Infarction in rats, infarct size, myocyte hypertrophy, and capillary growth. Circ. Res. 1986- Vol. 58(1): 26−37.
- Anversa P., Li P., Zang X., Olivetti G., Capasso J.M. Ischaemic myocardial injury and ventricular remodelling. Cardiovasc. Res. 1993- Vol. 27: 145−157.425 •
- Asahara T, Murohara T, Sullivan A. et al. Isolation of putative progenitor endothelial) cells for angiogenesis. Science 1997- 275: 964- 967.
- Aschoff L. Pathologische Anatomic. Jena, 1921. 356 p.
- Askari A.T., Unzek S., Popovic Z.B. et al. Effect of stromal-cell-derived factor 1 on stem-cell: homing and tissue regeneration" in ischaemic cardimyopa-thy. Lancet 2003- Vol.362(9385): 697−703.176.
- Bach D.S., Armstrong W.F., Donovan C.L., Muller D: W.M. Quantitative Doppler tissue imaging for assessment of myocardial velocities during transient ischemia and reperfusion: Am Heart J 1996- 132: 721−725.
- Balsam, L. B, Wagers A.J., Christensen J.L. et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004- 428: 668−673.
- Bar F.W., Meyer J., Vermeer F. et al. Comparison of saruplase and alteplase in acute myocardial infarction. Am J Cardiol 1997- 79: 727−732.
- Bardales RH,* Hailey S, Xie SS, Schafer RF, Hsu S-M. In situ apoptosis assay for the detection of early acute myocardialinfarction. Am J Pathol. 1996- 149: 821−829.
- Bartunec J, VanderheydemM, Vandekerckhove B et al. Intracoronary injection-of CD133+ enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005−112:1178−1183.
- Baserga R. The Biology of Cell Reproduction. Cambridge, Mass/London: Harvard University Press, 1985- 452.
- Baum H., Booksteegens P., Steinbeck. A rapid assay for the quantification of mtoglobin evaluation and diagnostic relevance in the diagnosis of AMI. Eur J. Clin Chem Clin Biochem 1994- 32: 853−858.
- Beller G.A. Diagnostic accuracy of thallium-201 myocardial perfusion imaging. Circulation 1991,84(3): 11−16.
- Beltrami A.P., Urbanek K., Kajstura J. et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl. J. Med. 2001- 344(23): 1750−1757.
- Beltrami A.P., Chimenti S., Limana F. et al. Cardiac c-kit positive cells proliferate in vitro and generate new myocardium in vivo. Circulation 2001- 104 (suppl II): 324.
- Beltrami CA, Finato N, Rocco M et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994- 89: 151−163.
- Bernhard M: Ventricular, remodeling. Cardiology 1996- 87: 2−10.
- Bittira B., Kuang J.-Q., Al-Khaldi A. et al. In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann. Thorac. Surg. 2002- 74: 1154−1160.
- Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001- 105: 829 841.
- Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction. J, Am Coll’Cardiol 2007- 50: 917−929.
- Boersma E., Mercado N., Poldermans D. et al. Acute myocardial infarction. Lancet 2003- 361: 847 858.
- Bolli R. Regeneration of the human heart no chimera? N. Engl. J. Med. 2002- 346(1): 55−56.
- Bolognese L., Neskovic A.N., Parodi G., et al. Left Ventricular Remodeling After Primary Coronary Angioplasty Patterns of Left Ventricular Dilation and Long-Term Prognostic Implications. Circulation 2002- 106: 2351−2357.
- Bonnefoy E, Lapostolle F, Leizorovicz A. et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.
- Lancet 2002- 360: 825−829.
- Bonow R.O., Dilsizian V. Thallium 201 for assessment of myocardial viability. Semin. Nucl. Med. 1991- 21(3): 230−241.
- Boyle AJ, Whitbourn’R, Schliht S. et al. Intracoronary high-dose CD34+ stem ' cells in patients with chronic ischemic heart disease: 12-month follow-up. Int
- J Cardiol 2006- 109: 21−27.
- Boyum A. Separation of leukocytes from blood and bone marrow. Scand.J.Clin.Lab.Investig. 1968- 21-Suppl.97: 1−9.
- Bozkurt B, Kribba SB, Clubb FJ et al. Pathophysiological^ relevant concentrations of TNF-a promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998- 97: 1382−1391.
- Brenner A, Stampfer MR, Aldac MC. Increased pi6*expression with first senescence arrest in human mammary epithelial' cells and extended growth capacity with pl6 inactivation. Oncogene 1998- 17: 199−205.
- Brodie BR- Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J. Cardiol 2000- 85: 13−18.
- Cannon CP," Gibson CM, Lambrew CT. et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time withf mortality in? patients undergoing angioplasty for acute myocardial infarction. JAMA 2000- 283: 29 412 947.
- Charney R., Schwinger M.E., Chun J. et al. Dobutamin echocardiography and resting-redistribution Thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am. Heart J. 1994- 128: 864−869.
- Chen S.L., Fang W.W., Ye F. Effect on left ventricular function-of intracoro-nary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004- 94(1): 92 95.
- Cheng W, Li B, Kajstura J et al! Stretch induced programmed* myocyte cell death. J Clin Invest 1995- 96: 2247 2259.
- Chien K.R. Stem cells: lost in-translation. Nature 2004- 428: 607−608.
- Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg. 1995- 60(1): 12 -18.
- Cloninger K.G., DePuey E.G., Garcia E.V. Incomplete redistribution in delayed Thallium-201 single-photon emission computer tomography (SPECT) images: overestimation of myocardial scarring. J. Am. Coll. Cardiol. 1988- V.12: 955−963.
- Clubb FJJr, Bishop SP. Formation of binucleated myocardial cells in the neonatal rat: an index for growth hypertrophy. Lab Invest. 1984- 50: 571 574.
- Collinson P. Troponin T or troponin" I or CR-MB (or none?). Eur Heart J 1998- 19: Suppl N: 16−24.
- Colucci W.S. Molecular and Cellular Mechanism of Myocardial Failure. Ami J'. Cardiol. 1997- 80 (11 A): 15L-25L.
- Connely C. M, Vogel W.M., Wiegner A.W. et al. Effects of reperfusion after coronary artery occlusionion post-infarction'scar tissue. Circ. Res. 1985- Vol: 57: 562−577.
- Coudrey L. The Troponins. Arch Int Med 1998- 158: 1173—1180.
- Crespo-Leiro M.G., Hunt S.A. One day update on heart failure. Eur Heart J 2006- 8(SupplE): E3-E6.
- Danchin N, BlanchardiD, Steg PG. et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004- 110: 1909—1915.
- Danchin N. Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction? Eur Heart J 2006- 27: 1131−1133.
- De LG, Suryapranata H- Ottervanger JP, Antman EM- Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004- 109: 1223−1225.
- Dib’N., Michler R.E., Pagani F.D., etal. Safety and1 feasibility of autologous myoblast transplantation in patients * with- ischaemic cardiomyopathy: four-year follow-up. Circulation 2005- 112: 1748−1755.
- Dimmeler S., Zeiher A.M., Schneider M.D., Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005- 115: 572 583.
- Drefius Ji, Schapiro G., Resnais J. et al. Serum creatine kinase in the diagnosis myocardial infarction. Rev Fr Etud Clin Biol 1960- 88: 750−763.
- Drexel-H, Dvorak E., Kirshmaier W. et al. Myoglobinemia in early phase of acute myocardial infarction. Am Heart J 1983- 105: 642- 650.
- Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002- 99: 9864−9869.
- Eagles K.A., Nallamothu B.K., Mehta R.H. et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008- 29: 609−617.
- Eaton L.W., Weiss J.L., Bulkley B.H., Garrison J.B., Weisfeldt M.L. Regional cardiac dilatation after acute myocardial infarction. Recognition by two-dimensional echocardiography. N. Engl. J. Med. 1979- 300(2): 57−62.
- Emilsson E, Alam M., Wandt A. The relation between mitral annulus motion and ejection fraction: A nonlinear function. J Am Soc Echocardiogr 2000- 13: 896−901.
- Emilsson E., Wandt A. The relation between ejection fraction and mitral annulus motion in atrial fibrillation. Clin Physiol 2000- 20: 44.49.1. A A
- Emilsson E., Wandt A. The relation between left ventricular ejection fraction and mitral annulus motion changes with age and heart size. Clin Physiol 2000- 20: 38−43.
- Erlebacher J.A., Weiss J.L., Eaton L.W. et al. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am. J. Cardiol. 1982- 49: 1120−1126.
- Etzion S., Battler A., Barbash I.M. et al. Influence of embryonic cardiomyo-cyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J. Mol. Cell. Cardiol. 2001- 33 (7): 1321 1330.
- Factor S.M., Flomenbaum M., Zhao MJ. et al. The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue. J. Am. Coll. Cardiol. 1988- 12: 1582−1589.
- Fernandez-Aviles F., San Roman J.A., Garcia Frade J. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ.Res. 2004- 95: 742−748.
- Frangogiannis NG, Mendoza LH, Lindsey ML, et al. IL-10 Is Induced in the Reperfused Myocardium and May Modulate the Reaction to Injury. The Journal of Immunology 2000- 165: 2798 2808.
- Friedenstein A.J., Petrakova K.V., Kurolesova A.I. et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968- 6 (2): 230−247.
- Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001- 37: 1726 -1732.
- Fuchs S, Comowski R, Mehran L et al. The deleterious Prognostic impact of cardiac troponin I re-elevation following percutaneous coronary intervention in patients with acute coronary syndromes. J Am Coll Cardiol 2000- 35 Suppl A: 75.
- Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003- 41: 1721 1724.
- Fuji T, Yau TM, Weisel RD et al. Cell transplantation to prevent heart failure: a comparison of cell types. Ann Thorac Surg. 2003- 76(6): 2062 2070.
- Fukuda E., Oki O., Tabata O. et al. Regional left ventricular wall motion abnormalities in myocardial infarction and mitral annular descent velocities studied with pulsed tissue Doppler imaging. J Am Soc Echocardiogr 1998- 11: 841−848.
- Galianes M, Loubani M, Davies J et al. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhanced cardiac function in humans. Cell Transplantat 2004- 364: 141 148.
- Galinanes M., Loubani M., Davies J. et al. Safety and efficacy of transplantation" of autologous bone marrow into scarred myocardium for the enhancement of cardiac function in man. Circulation 2002- 106 (Suppl II): 11−463. Abstract 2292.
- Galiuto L., Ignone G., DeMaria A.N. Contraction and relaxation velocities of the normal left ventricle using pulsed-wave tissue Doppler chocardiography. Am J Cardiol 1998- 81: 609−614.
- Garcia E., Elizaga J., Perez-Castellano N. et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999−33:605−611.
- Geng YJ. Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 2003- 1010: 687 697.
- Gepstein L. Derivation-and potential applications of human embryonic stem cells. Circ Res 2002- 91: 866 876.
- Ghostine S., Carrion C., Souza L.C. et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002- 106 12Suppl 1.: I-131-I-136.
- Glaser R., Lu M.M., Narula N., et al. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002- 106: 17−19.
- Glatz J.F., van Bilsen M., PaulussenR.J., Sawlivich W.B. et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim BiophysActa 1988- 961(1): 148−152:
- Glover M.B., Adgey A. A J. Acute reperfusion strategies for ST-segment elevation myocardial infarction. Eur Heart J 2008- 29: 571−572.
- Good D. Stem- Cell Transplantation Not Ready for Prime Time. http://www.medscape.com/viewarticle/440 985.
- Gorsan J. 3rd., Strum D.P., Mandarino W.A. et al. Quantitative assesment oa altration in- regional left ventricular contractility with color-coded tissue
- Doppler echocardiography. Comparison with sonomicrometry and pressure-volume relations. Circulation 1997- 95: 2423- 2433.
- Grande P., Cristiansen C., Alsrup K. et al. Comparison of ASAT, CK, CK-MB and LD for estimation infarct size in man. Clin Chem 1983- 128: 329 335.
- Grines C.L., Nissen S.E., Booth D.C. t al. A prospective randomised trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Circulation 1991- 84: 540−9.
- Grines C.L., Serruys P., O’Neill W.W. Fibrinolytic therapy. Is it a treatment of the past? Circulation. 2003- 107: 2538−2542.
- Grines C.L., Browne K.F., Marco J. et al. A comparison of immediate angioplasty: with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction N Engl J Med 1993- 328: 673−679.
- Grines C.L., Cox D.A., Stone G.W., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999- 341: 19 491 956.
- Grinfeld L., Berrocal D., Bellardi J. Fibrinolytics versus primary angioplasty in acute myocardial infarction (FAP): a randmozied trial in a community hospital in Argentina. J Am Coll Cardiol 1996- 27: Suppl: A222.
- Grossman W., Lorel B.N. Hemodynamic aspects of left ventricular remodeling after myocardial infarction. Circulation* 1993- 87(Suppl. VII): VII-28-VII-30.
- Hochman J. S, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987- 75: 299−306.
- Grove J.E., Bruscia E., Krause D.S. Plasticity of bone marrow derived stem cells. Stem cell 2004- 22: 487−500.
- Gruppo Italiano per lo Studio della Streptochinasi nell’infarcto myocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986- 1: 397−401.
- Guerra S, Leri A, Wang X et al. Myocyte death in the failing human heart is gender dependent. Circ Res. 1999- 85: 856 866.
- Guidry U.C., Evans JlC., Larson M.G. Temporal trends in event rates after q-wave myocardial infarction. Circulation 1999- 100: 2054−2059.
- Gulati V.K., Katz W.E., Follansbee W.P., Grossan III J. Mitral' annular descent" velocity by tissue Doppler echocardiography as an index of global4- left ventricular function. Am. J- Cardiology 1996- 77: 979−984.
- Gupta M, Chang WC, Van de WF. et al. International differences in inhospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2. Eur Heart J 2003- 24: 1640−1650.
- GUSTO Angiographic Investigator. N Engl. J. Med., 1993- 329:1615.
- Hamano K., Nishida M., Hirata K. et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn. Circ. J. 2001- 65(9): 845 847.
- Hambretch’R, Erbs S, Thiele H et al- Intracoronary transplantation of circulating progenitor cells after recanalization of chronic coronary artery occlusions: long-term effects on left ventricular function. Circulation 2005- 112(Suppl. II): 581.
- Hamm C.W., Bertrand M.E., Braunwald E. Acute coronary syndromes without ST elevation: implementation of new guadelines. Lancet 2001- 358: 1533 -1538.
- Hamsten A., Walldius G., Szamosi A. Plasminogen activator in plasma: risk factor for recurrent myocardial infarction. Lancet 1987- 3−8.
- Hartmann F., Kampmann M., Frey N. et al. Biochemical markers in the diagnosis of coronary artery disease. Eur Heart J 1998- 19: Suppl N: 2−7.
- Hasdai D., Behar S., Boyko V., Danchin N., Battler A., Bassand J.P. Cardiac biomarkers and acute coronary syndromes—The Euro Heart-Survey of Acute Coronary Syndromes Experience. European Heart Journal 2003- 24: 11 891 194.
- Hasper D, HummeL M, Kleber FX. Systemic inflammation in patients with heart failure. EupHeart J^ 1998- 19: 761−765.
- He JQ, Ma Y, Lee Y et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003- 93: 32−39.
- Heras M., J. Chesebro, B. Gersh et al. Emergency thrombolysis in acute myocardial infarction. Ann. Emerg. Med. 1988- 17(11): 1163/67−1174/73.
- Herreros J., Prosper F., Perez A. et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003- 24: 2012 2020:
- Hiller E. Grundlagen der Therapie mit Fibrinolytika. Fortschr.Med. 1986- Bd.104 N 30: S. 571/21−574/24.
- Hillis G.S., Terrigino CA, Toggart P et al. Inflammatory cytokines provide limited* early prognostic information in emergency department patients with suspected myocardial ischemia. Ann. Emerg. Med. 2003- 42 (3): 337 42.
- Hirschi K.K., Goodell M.A. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther. 2002- 9 (10): 648−652.
- Hirsh J., Raschke R., Warkentin T.E. et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995- 108: 258S 275S.
- Hofmann M, Wollert K, Meyer G. Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium. Circulation. 2005- 111: 2198 2202. .
- Hughes S. Cardiac stem cells. L Physiology 2002- 197: 468−478.
- Hutcheson K.A., Atkins B.Z., Hopkins M.B. et al. Comparing Cell Types for Cellular Cardiomyoplasty: Analysis of Improved Diastolic Properties with Autologous Skeletal Myoblasts and Fibroblasts. Circulation 1999- 100(suppl I): 1−118.
- Hutcheson K.A., Atkins B.Z., Hueman M.T. et al. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell. Transplant. 2000- 9 (3): 359−368.
- Hutchins G.M., Bulkley B.N. Correlation of myocardial contraction band necrosis and vascular patency: a study of coronary artery bypass graft anastamoses at branch points. Lab. Invest. 1977- 36: 642−648.
- Hutchins G.M., Bulkley B.N. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am. J. Cardiol. 1978- 41(7): 1127−1132.
- Hwang M., Matsumori A., Furukawa Y. et al. Neutralization of interleukin-1 beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol. 2001- 38: 1546 1553.
- ISIS-II (Second International Study of Infarct Survival). Randomized Trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988- 2: 349−360.
- Jackson K.A., Majka S.M., Wang H. et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 2001- 107 (11): 1395- 1402.
- Jain M., DerSimonian H., Brenner D.A. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001- 103: 1920−1927.
- Janssens S., Dubois C., Boogaerts M. et al. Autologous bone marrow-derived stem-cell transfer in patients with, ST-segment elevation myocardial infarction. Lancet 2006- 367: 141−148.
- Jenni R., Ritter M., Vieli A. et al. Echocardigraphic assessment of pressure in pulmonary artery. Brit. Heart J. 1989- Vol.61: 167−171.
- Juliard J.M., Feldman L.J., Golmard J.L. et al. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. Am J Cardiol 2003- 91: 1401−1405.
- Kajstura J., Fiordaliso F., Andreoli A.M. et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes. 2001- 50: 1414 1424.
- Kajstura J., Leri A., Finato N. et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 1998- 95: 8801−8805.
- Kajstura J., Zhang X., Reiss K. et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ. Res. 1994- 74(3): 383−400.
- Kamihata H, Matsubara H, Nishiue T. et al. Improvement of collateral perfusion and regional function, by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vase Biol. 2002- 22(11): 1804- 10.
- Kannel W.B., Sorlie P., McNamara PM. Prognosis after initial myocardial, infarction: The Framingham Study. Am. J. Cardiol. 1979- 44: 53−59.
- Karla K.D., Zhu X., Ramchandani K.M. et al. Increased myocardial gene expression of tumor necrosis factor and' nitric oxide synthase-2. Circulation 2002- 105:1537−1540.
- Karsner H.T., Saphir O., Todd T.W. The state of the cardiac muscle in hypertrophy and atrophy. Am. J. Pathol. 1925- 1: 351−371.
- Kastrati A, Mehilli J, Dirschinger J. et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomized trial. Lancet 2002- 359: 920−925.
- Katritsis D.G., Sotiropoulou P.A., Karvouni E. et al. Transcoronary transplantation of autologous mesenchymal stem cells and^endothelial-progenitors into infarcted human myocardium. Catheter Cardiovasc Interv. 2005- 65(3): 321 -329.
- Katus H., Diederich K., RemppisA. et al. Influence of reperfusion on serum concentration of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol 1987- 60: 440−445.
- Kaufmann E. Specielle pathologische Anatomie. Berlin/Leizig, 1922- 345.,
- Kaul P.,' Chang W.-C., Lincoff A.M. et al. Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO V trial. Eur Heart J 2006- 27: 1198−1206.
- Kaur K., Sharma A. K., Singal P. K. Significance of changes in TNF- and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 2006- 291: H106 HI 13.
- Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can ¦ differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001- 108: 407 414.
- Kennedy J., Gensini G., Timmis G. et al. Acute myocardial infarction treted with intracoronary streptokinase: a report of the Society for Cardiac Angiography. Amer. J.Cardiol. 1985- 55(8) 871−877.
- Killip T, Kimball J.T. A survey of the cotonary care unit: concept and results. Progr. Cardiovasc. Research 1968- 11: 45 51.
- Killip T., Kimball J.T., Treatment of myocardial infarction in coronary care unit. Am J Cardiol 1967- 20: 457−464.
- Kim W.H., Joo C.U., Ku J.H. et al. Cell cycle regulators during human atrial development. Korean J Intern Med. 1998- 13(2): 77−82.
- Kircer B., Topol E., W. OvNeill et al. Prediction of infarct coronary artery re-canalization after intravenous thrombolytic therapy. Amer. J.Cardiol. 1987- 59(6): 513−515.
- Kishore B.S. Pasumarthi, Field Loren J. Cardiomyocyte Cell Cycle Regula-tion^Circulation Research. 2002- 90: 1044 1065.
- Kitabatake A., Inoue M., Asao M. et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. 1983- 68: 2: 302−309.
- Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyo-cytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996- 98: 216 224.
- Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocite apoptosis, reduce remodeling and improves cardiac function. Nat. Med. 2001- 7: 430−436.
- Kofidis T, de Bruin JL, Tanaka M et al. They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur J Cardiothorac Surg 2005- 28: 461- 466.
- Koh G.Y., Klug M.G., Soonpaa M.H. et al. Differentiation and long-term survival of C2C12 myoblast’grafts in heart. J Clin Invest 1993- 92(3): 1548 -54.
- Koh G.Y., Soonpaa M.H., Klug M.G., et al. Strategies for myocardial repair. J Interv Cardiol. 1995- 8(4): 387−393.
- Konermann M., Sanner B.M., Horstmann E. et al. Changes of the left ventricle after myocardial infarction estimation with cine magnetic resonance imaging during the first six month. Clin. Cardiol. 1997- 20(3): 201−212.
- Korup E., Dalsgaard D., Nyvad O. et al. Comparison of degrees of left ventricular dilation within three hours and up to six days after onset of first acute myocardial infarction. Am. J. Cardiol. 1997−80(15): 449−453.
- Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage en-graftment by a single bone marrow-derived stem cell. Cell. 2001- 105:369 377.
- Kuethe F, Richartz BM, Kasper C, et al. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol 2005- 100: 485 491.
- Kuethe F, Richartz BM, Sayer HG, et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarction. Int J Cardiol 2004- 97: 123 -127.
- Kuettner H. Verimpfung an stelle der transplantation hochwertiger organe. Zentralblatt fur Chirugie 1:390−397, 1912., as cited in Popov I M and others. Journal of the International Academy of Preventive Medicine 1977- 1(40): 7482.
- LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002- 111: 589−601.
- Laflamme M.A., Myerson D., Saffitz J.E., Murry C.E. Evidence for cardi-omyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 2002- 90(6): 634−640.
- Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005- 23: 845−856.
- Lamas G.A., Pfeffer M.A. Left ventricular remodeling after acute myocardial infarction: clinical course and beneficial effects of angiotens in-converting enzyme inhibition. Am. Heart. J. 1991- 121(4): Part, i: 1194−1202.
- Lange R.A., Hillis L.D. Reperfusion Therapy in Acute Myocardial Infarction. N Eng. J. Med. 2003- 346: 954−955.
- Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice: the role of SDF-1/CXCR4 interactions. Ann NY Acad Sci 2001- (938): 83−95.
- Lawson M.A., Johnson L.L., Coghlan L. et al. Correlation of thallium uptake with left ventricular wall thickness by cine magnetic resonance imaging in patients with acute and healed myocardial infarcts. Am. J. Cardiol. 1997- 80(15): 434−441.
- Le May M. R,. Labinaz M., Davies R.F. et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll’Cardiol 2001- 37: 985 991.
- Lee H.-O, Eisenberg M.J., Schiller N.B. Serial assessment of left ventricular function after myocardial infarction. Am. Heart. J. 1995- 130: 999−1002.
- Lemos P.A., Saia F., Hofma S.H. et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients withacute myocardial infarction. JAm Goll Cardiol 2004- 43: 704—'708:
- Leor J., Aboulafia-Etzion S., Dar A. et al. Bioengineered Grafts to Repair the Infarcted Myocardium. A New Approach to Repair the Infarcted Myocardium? Circulation 2000−102 suppl III.: III-56-III-61.
- Leor J., Patterson M., Qumones M.J. et al. Transplantation of Fetal Myocardial Tissue Into the Infarcted Myocardium of Rat A Potential Method for Repair of Infarcted Myocardium? Circulation 1996- 94suppl II.: 11−332−11−336.
- Leri A., Barlucchi L., Limana F., et al. Telomerase expression and activity are coupled with myocyte proliferation andipreservation of telomeric length in the failing heart. Proc Natl Acad Sei USA. 2001- 98: 8626 8631.
- Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005- 85: 1373 1416.
- Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol. 1996- 28: 1737−1746.
- Li Q, Li B, Wang X, et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997- 100: 19 911 999.
- Li R.K., Mickle D.A., Weisel R.D. et al- Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann. Thorac. Surg. 2001. Vol.72 (6).-P. 1957−1963.
- Li R.K., Weisel R.D., Mickle D.A. et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J. Thorac. Cardiovasc. Surg. 2000- 119 (1): 62−68.
- Li R.K., Jia Z.Q., Weisel R.D. et al. Smooth Muscle Cell Transplantation into Myocardial Scar Tissue Improves Heart Function. J Mol-Cell Cardiol. 1999- 31: 513−522.
- Li R-K, Jia Z-Q, Weisel R.D.% et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 1996- 62: 654 661.
- Li R.K., Mickle D.A.G., Weisel R.D. et al. Natural history of fetal rat cardi-omyocytes transplanted into adult rat myocardial scar tissue. Circulation 1997- 96(suppMI): II-179−11−187.
- Li R.K., Yau T. M1, Sakai T. et al. Cell therapy to repair broken hearts. Can J Cardiol. 1998- 14(5): 735−744.
- Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001- 104: 365 372.
- Limana F., Urbanek K., Chimenti S. et al. bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 2002- 99: 6257 6262.
- Limbourg FP, Drexler H. Bone marrow stem cells for myocardial infarction: effector or mediator? Circ Res 2005- 96: 6 8.
- Lin GS, Lu JJ, Jiang XJ et al. Autologous transplantation of bone marrow mononuclear cells improved heart function after myocardial infarction. Acta Pharmacol Sin. 2004- 25(7): 876 886.
- Lincoff A.M., Topol E.J. Illusion of reperfusion. Does anyone achive optimal reperfusion during acute myocardial infarction? Circulation 1993- 88(3): 1361−1374.
- Linzbach A.J. Akumoa-Boateng E. Die Alternsveranderungen des menschlichen Herzens I. Die Herzgewicht im Alter. Klin. Wochenschr. 1973- 51: 156 163.
- Linzbach A.J. Heart failure from the point of view of quantitative anatomy. Am. J. Cardiol. 1960- 5: 370−382.
- Linzbach AJ. Mikrometrische und hystologische Analyse hypertropher menschlicher Herzen. Virchow Arch. Pathol. Anat. Physiol. 1947- 314: 534−594.
- Linzbach A.J. Muskelfaserkonstante und das Wachstumsgesetz der menschlichen Herzkammern. Virchows Arch. 1950- 318: 575−618.
- Lishmanov Yu.B., Chernov V.l., Vesnina J.V. et al. Myocardial perfusion and left ventricular function in long-term follow-up and prognosis of electrostimulation cardiomyoplasty. Nuclear Med. Rev. 2000- 3 (1) — 21−27.
- Lo Y. Intravenous versus intracoronary streptokinase in acute myocardial infarction. Clin.Cardiol. 1985- 8: 609−619
- Luc G, Bard JM, Juhan-Vague I, et al. C-reactive protein, interleukine-6, and fibrogenes as predictors of coronary heart disease: the PRIME study. Arterioscler. Thromb. Vase. Biol. 2003- 23 (7): 1255 1261.
- Lunde K., Solheim S., Aakhus S. et al. Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction. N Engl J Med 2006- 355: 1199 1209.
- Makino S., Fukuda K., Miyoshi S. et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999- 103 (5): 697−705.
- Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003- 9: 1195- 1201.
- Mann L.D. Mechanism and models in heart failure. Circulation 1999- 100: 999−1008.
- Marat T, Doulet LT. Revascularization in ischemic heart with autologous bone marrow transplantation. Jpn J Cardiovasc Surg. 1997- 26: 248 253.
- Marchiniak A, Gerblinski I, Stefanski R- et al. Predictive value of plasma in-terleukine-1, interleukine-6, interleukine-8 and C-reactive protein in patients with myocardial infarction. J. Pol. Arch. Med. Wewn. 2003- 109 (1): 15−22.
- Maron B.J. Structural features of the athlete heart as defined by echocardiography. J. Am. Coll. Cardiol. 1986- 7: 190−203.
- Martin G. St. J. S., Norman S. Left Ventricular Remodeling After Myocardial Infarction. Circulation 2000- 101:2981−2987.
- Matsushita T., Oyamada M., Kurata H. et al. Formation of Cell Junctions between Grafted and Host Cardiomyocytes at the Border Zone of Rat Myocardial Infarction. Circulation 1999- 100suppl II.: II-262-II-268.
- Melandri G. The obsession with primary angioplasty. Circulation 2003- 108: el62.
- Menasche P., Hagege A.A., Scorsin M. etal. Myoblast transplantation for heart failure. Lancet 2001- 357: 279 -280.
- Menasche P, Hagege AA, Vilquin JT, etal. Autologous skeletal myoblast transplantation for severe post infarction left ventricular dysfunction. J Am Coll Cardiol. 2003- 41(7): 1078 1083.
- Menasche P.", Hagege A.A., Vilquin J.T. et al. Autologous skeletal, myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 2003- 41 (7): 1078−1083.
- Mentzer P., Budzynsci A., Sherry S. High-dose, brief-duration intravenous infusion of streptokynase in acute myocardial. infarction: description of effects in the circulation. Amer J.Cardiol. 1986- Vol.57: 1220−1226.
- Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein Ilb/IIIa inhibition with" coronary stenting for acute myocardial infarction. N Engl J Med. 2001- 344: 1895−1903.
- Muller P, Pfeiffer P, Koglin J, et al: Cardiomyocytes of non-cardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 2002- 106: 31−35.
- Muller-Ehmsen J, Peterson KL, Kedes L, et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002- 105: 1720 -1726.
- Murry C.E., Wiseman R.W., Schwartz S.M. et al. Skeletal Myoblast Transplantation for Repair of Myocardial Necrosis. J Clin Invest 1996- 98:25 122 523.
- Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005- 112: 3174 3183.
- Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004- 428: 664 668.
- Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Circulation Research 2003- 92: 139−150.
- Nagueh S.F., Middleton K.J., Kopelen H.A. et al". Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997- 30: 1527−1533.
- Nallamothu B.K., Bates E.R. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003- 92: 824—826.
- Ndrepepa J., Kastrati A., Neumann F. et al. Five-year outcome of patients with acute myocardial infarction enrolled in randomized trial assessing the value of abciximab during coronary artery stenting. European Heart Journal 2004- 25: 1635−1640.
- Neirinckx R.D., Burke J: F., Harrison R.C., et al. The retention mechanism of technetium-99m HMPAO: intracellular reaction with glutathione. J. Cereb. Blood Flow Metab. 1988- V8: S4 (Suppl).
- Neuhaus K. Methodology and results of intravenous thrombolysis in acute myocardial infarction. Cardiovasc.Intervent.Radiol. 1986- 9(30): 253−257
- Nian M., Lee P., Khaper N., Liu P. Inflammatory Cytokines and Postmyocar-dial Infarction Remodeling. Circulation Research 2004- 94: 1543 1553.
- Nicolosi G.L. Cardiac remodeling and failure after myocardial infarction. J. Cardiovasc. Risk. 1994- 1(4): 310−313.
- Norol F., Merlet P., Isnard R., et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood. 2003- 102: 43 614 368.
- NRMI-4 Investigators. The National Registry of Myocardial nfarction-4 Quarterly Report 2003- 2.
- Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004- 10: 494 501.
- Olivetti G., Capasso J.M., Sonnenblick E.H., Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ. Res. 1990- 67: 23−34.
- Orlic D, Kajstura J., Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001- 410: 701−705.
- Orlic D. Stem cell repair in ischemic heart disease: an experimental model. Int. J. Hematol. 2002- 76: 1: 144−145.
- Orlic D., Hill J.M., Arai A.E. Stem cells for myocardial regeneration. Circ. Res. 2002- 91(12): 1092- 1102.
- Orlic D., Kajstura J., Chimenti S. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA. 2001- 98(18): 10 344−10 349.
- Orlic D., Kajstura" J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001- 410: 701−705.
- Pacouret G., Charbonnier B., Curien N.D. et al. Invasive reperfusion study II. Multicentre European randomized trial of anistreplase vs streptokinase in acute myocardial infarction. Eur. Heart J: 1991- 12: 179−85.
- Penicka M., Widimsky P., Kobylka P., Kozak T., Lang O. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 2005- 112: e63 -e65.
- Penn M.S., Zhang M., Deglurkar I. et al. Role of stem cell homing in myocardial regeneration. International. J. Cardiol. 2004- 95(Suppl 1): S23-S25.
- Penn M.S., Zhang M., Deglurkar I., Topol E.J. Role of stem cell homing in myocardial regeneration. Int. J. Card. 2004- 95 (Suppl.l): S23-S25.
- Perin E.G., Dohmann H.F., Borojevic R., et al. Transendocardial- autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003- 107: 2294−2302.
- Pfeffer J.M., Pfeffer M.A., Braunwald E. Influence of chronic Captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 1985- 57: 84−95-
- Pfeffer J.M., Pfeffer M.A., BraunwaldiE. Influence of chronic Captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 1985- 57: 84−95.
- Pfeffer M. A, Pfeffer J.M. Ventricular enlargement and reduced. survival after myocardial infarction. Circulation 1987- 75(Suppl. 4): IV-93-IV-97.
- Pfeffer M. A, Pfeffer J.M., Fishbein M.C. et al. Myocardial infarct size and ventricular function in rat. Circ. Res. 1979- 44: 503−512
- Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction-. Experimental observations and clinical implications: Circulation 1990- 81(4): 1161−1172.
- Pfeffer M.A., Lamas G.A., Vaughan D.E. et al. Effect of Captopril on progres. sive ventricular dilatation after anterior myocardial infarction. N. Engl. J.1. Med. 1988- 319: 80−86:
- Picard M.H., Wilkins G.T., Ray P.A., Weyman A.E. Progressive changes in ventricular structure and function during the year after acute myocardial infarction. Am. Heart: J. 1992- 124(1): 24−31.
- Pierard L.A., Albert A., Gilis F. et al. Hemodynamic profile of patients with acute myocardial infarction of risk at infarct expansion. Am. J. Cardiol. 1987- 60(1): 5−9.
- Pieske B. Reverse remodeling in heart failure fact or fiction? European Heart Journal Supplements 2004- Vol. 6: Suppl. D 66−78.
- Pouzet B., Ghostine S., Vilquin J.T. etal. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 2001- 104 12 Suppl 1.: I-223-I-228.
- Quaini F., Urbanek K., Beltrami A. et al. Chimerism of the transplanted heart. N Engl J Med. 2002-.346: 5 15.
- Reinecke H., MacDonald G.H., Hauschka S.D. et' al. Electromechanical Coupling between Skeletal and Cardiac Muscle: Implications for Infarct Repair. J Cell Biol. 2000- 149: 731−740.
- Reinecke H, Poppa V, Murry CE. Skeletal-Muscle Stem" Cells Do Not Trans- ' differentiate Into Cardiomyocytes After Cardiac Grafting. J Mol Cell Cardiol. 2002- 34: 241−249.
- Reinecke H, Zhang M, Bartosek T et al. Survival, Integration and Differentiation of Cardiomyocyte Grafts. A Study in Normal and. Injured Rat Hearts. Circulationl999- 100: 193 202.
- Reubinoff B.E., Pera M.F., Fong C.Y. et al. Embryonic stem celMines from human blastocysts: somatic differentiation1 in vitro. Nature Biotechnology 2000- 18 (4)r399−404.
- Ribeiro E.E., Silva L.A., Carneiro R. et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993- 22: 376—380.
- Richard A. Lange, L. David Hillis. Reperfusion therapy in acute myocardial infarction. NEJM, 2002- 13(346): 954−955.
- Ridker P.', Rifai N., Pfeffer M., et al. Elevation of Tumor Necrosis Factor-nr and Increased Risk of Recurrent Coronary Events after Myocardial Infarction. Circulation 2000- 101: 2149 2153.
- Rott D., Behar S., Gottlieb S. Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990 s compared with those treated in the 1980s. Am J Cardiol. 1997- 80: 859−864.
- Rumyantsev PP. In: Carlson BM, ed. Reproduction of Growth and Hyperplasia of Cardiac Muscle Cells. Chur, Switzerland: Harwood. Academic Publishers- 1991- 3: 1−371.
- Ryden E., Remme W.J. Treatment of congestive heart failure. European Heart Journal. 1999- 20: 867 871.
- Sabbah H.N., Goldstein S. Ventricular remodelling: consequences and therapy Eur. Heart. J. 1993- 14: 24−29.
- Sachinidis A., Kolossov E., Fleischmann B.K.et al. Generation of cardiomyo-cytes from embryonic stem cells experimental studies. Herz 2002- 27(7): 589 597.
- Sadoshima J., Xu J, Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993" — 75: 977−984.
- Saito T, et al. Myogenic expression of mesenchimal stem cells within myo-tubes of mdx mice in vitro and in vivo. Tissue Eng. 1995- 1: 327−343.
- Sakai T, Li RK, Weisel RD et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 1999- 118(4): 715 24.
- Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002- 99: 2703−2711
- Sanches P, Villa A, San Roman JA, et al. Percutaneous bone-marrow-derived cell transplantation: clinical observations. Eur Heart J 2006- 8, Suppl. H: H23 E31.
- Schachinger V., Erbs S., Elsiisser W., et al. Intracoronary Bone Marrow-Derived Progenitor Cells in Acute Myocardial Infarction. N Engl J Med 2006- 355: 1210−1221.
- Schafer A., Meyer G.P., Fuchs M. et al. Impact of intracoronary Bone Marrow Cell Transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006- 27: 929 935.
- Schaper J- Elsasser A, Kostin S. The role of cell death in heart failure. Circ Res. 1999- 85: 867−869.
- Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional' echocardiography. J Am Soc Echocardiogr 1989- 2: 356 368.
- Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein Ilb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000- 343: 385 391.
- Schroder R., Biamino G., von Leitner. et al. Intravenous Streptocinase Infusion beim acuten Myocardinfarct. Dtsch Med Wschr 1981, 106: 294−297.
- Seiler C., Pohl T., Wustmann K. et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease. Circulation 2001- 104: 2012.
- Serruys P.W. First-in-man transcatheter results. Presented at Transcatheter Cardiovascular Therapeutics 2002. Sept. 24−28, 2002. Washington, D.C. http://www.bioheartinc.com/clinical.php.
- Setoguchi M., Leri A., Wang S., et al. Activation of cyclins and cyclin-dependent kinases, DNA synthesis, and myocyte mitotic division in pacing-inducing heart failure in dogs. Lab Invest. 1999- 79: 1545 1558.A
- Shan E., Bick R.J., Poindexter B.J. et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and betaadrenergic receptor density in humans. J Am Coll Cardiol 2000- 36: 891−896.
- Shibata M, Endo S, Inada K, et al. Elevated levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997- 17: 145 150.
- Siminiak T., Kalawski R, Fiszer D et al. Transplantation of autologous skeletal myoblasts in the treatment of patients with post infarction heart failure. Circulation 2002- 106 (Suppl. II): II 636.
- Siminiak T, Kalawski R, Fiszer D, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004- 148: 531 537.
- Siminiak T. Patients' own young muscle cells for transplantation into heart. XXIV Congress of European Society of Cardiology. Press Conference Press release.- 3 Sept 2002.
- Simonson J.S., Schiller N.B. Descent of base of the left ventricle: an echocardiography index of the left ventricular function. J. Am. Soc. Echocardiography 1989- 2: 25−35.
- Singla DK, Hacker TA, Ma L, et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol. 2006−40(1): 195 200.
- Sobel B., Marcham R., Karlsberg R. et al. The nature of disappearance of creatine kinase from the circulation and its influence on enzymatic estimation of infarct size. Circ Res 1977- 41: 836—844.
- Soonpaa M.H., Field L.J. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol. 1997- 272: H220 -H226.
- Soonpaa M.H., Kim K.K., Pajak L., Franklin M., Field L.J. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol. 1996−271: H2183 H2189.
- Soonpaa M.H., Koh G.Y., Klug M: G. et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994- 264- 98 101.
- Sorajja P., Gersh B.J., Gox D.A. et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percu-taneose coronary intervention for acute myocardial infarction. Eur Heart J 2007- 28: 1709 1716.
- Stamm C., Kleine H.D., Westfal B., ct al. CABG and bone marrow cell transplantation after myocardial infarction. J Thorac Cardivasc Surg 2004- 52: 152 158. ' - :
- Stamm C., Westphal B., Kleine H.D. et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003- 361: 45−46.
- Steen R., Morkrid L., Tjonnfjord G-E., Egeland T. c-kit Ligand combined-with GM-CSF and/or IL-3 can expand CD34+ hematopoietic progenitor subsets for several weeks in vitro. Stem Cells 1994- 12: 214 224.
- Stencstrand U., Wallentin L. Early revascularisation and 1-ycar survival in 14-day survivors of acute. myocardial infarction: a prospective cohort study. Lancet 2002- 359: 1805 -1811. ¦
- Stone G.W., Grines C.L., Cox D.A., et al: Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002- 346: 957 966.
- Strauer B, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. J Am Coll Cardiol 2005- 46: 1651−1658.
- Strauer B., Kornowski R. Stem Cell Therapy in Perspective. Circulation 2003- 107: 929 934.
- Strauer B.E., Brehm M., Zeus T. et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002- 106: 1913 1918.
- Straumann E, Yoon S, Naegeli B. et al. Hospital transfer for primary coronary angioplasty in high risk patients with acute myocardial infarction. Heart 1999- 82: 415−419.
- Sutherlend G.R., Hatle L., Rademakers F.E. et al. Doppler myocardial imaging. A Textbook. Leuven University Press, 2003- 188.
- Sutton M.J., Norman Sharpe. Left Ventricular Remodeling After Myocardial Infarction. Circulation 2000- 101: 2981.
- Suzuki K., Murtuza B., Smolensk! R.T. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myobalsts. Circulation 2001- Vol. 104 Suppl. 1.: I-207-I-212.
- Suzuki K., Smolenski R.T., Jayakumar J. et al. Heart shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 2000- 109 19 Suppl. 3.: III-216-III-221.
- Swedberg K., Cleland J., Dargie H., et al. Guidelines for the Diagnosis and Treatment of Chronic Heart Failure. EHJ 2005- 26: 1115 1140.
- SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction: SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. BMJ 1991- 302: 555−560.
- Tatu G, Graiu E., State M. et al. Accelerated streptokinase in acute myocardial infarction: the preliminary results of the Romanian multicentric study (ROMAS-1). Eur. Heart J. 1998- 19: 280. .
- Taylor D< A: Cell-based repair: How should we: proceed? International Journal' of Cardiolgy 2004- 95 Suppl 1.: S8-S12.
- Taylor D-A., HrubanR-,. Rodriguez-E-R, GbldschmidtrClermont PT:.Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what. degree? Circulation 2002-T06(l): 2−4-
- Teerlink J.R., Goldhaber S.Z., Pfeffer M.A. An overviw of: contemporary etiologies of congestive heart failure. Am. Heart. J. 1991- 121: 1852−1853.
- Terrin M.L., Williams D.O., Kleiman N. et al. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial. J Am Coll Cardiol 1993- 22: 1763−1772.
- The Continuous infusion versus double-bolus administration of Alteplase (COBALT) investigators. A. comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction- N Engl J Med 1997- 337: 1124−30.
- The GUSTO Investigator. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993- 389: 673−82.
- The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N. Engl. J. Med. 1983- 309: 331−336.
- Theroux P., Ross J.Jr., Franklin D. et al. Regional myocardial function and dimensions early and late after myocardial infarction in the unanesthetized dog. Circ. Res. 1977- 40: 158−165.
- Thomson J. A., Itskovitzeldor, J., Shapiro, S. S., et al. et al. Embryonic stem cell lines derived from human blastocyst. Science 1998- 282: 1145−1147.
- Thum T., Bauersachs J., Poole-Wilson P.A., Volk H. D, Anker S.D. The dying stem' cell hypothesis: immune modulation as a novel mechanism for progenitor cell, therapy in cardiac muscle. J Am Coll Cardiol 2005- 46: 1799 -1802.
- Tian L., Catt J.W., O’Neill C. et al. Expression of immunoglobulin superfami-ly cell adhesion molecules on murine embryonic stem cells. Biol Reprod 1997- 57: 561−568.
- Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cell inproves damaged heart function. Circulation 1999- 100(suppl II): II-247−11−256.
- Topol E.J. Current Status and Future Prospects for Acute Myocardial Infarction Therapy. Circulation 2003- 108 suppl III.: III-6-III-13.
- Topol E.J. Reperfiision therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein Ilb/IIIa inhibition: the GUSTO V randomized trial. Lancet 2001- 357: 1905−1914.
- Topol E.J., Ohman E.M., Armstrong P.W. et al. Survival outcomes 1 year after reperfusion i therapy with either alteplase or reteplase for acute myocardial infarction. Circulation 2000- 102: 1761−1765. .
- Tsai RY, Kittappa R, McKay RD. Plasticity, niches, and the use of stem cells. Dev Cell. 2002- 2: 707−712.
- Tse H.F., Kwong Y.L., Chan J.K.F. et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003- 361: 47−49.
- Van Den Bos E.J., Taylor D.A. Cardiac transplantation of skeletal myoblasts for heart heat failure. Minerva Cardiologica 2003- 51(2): 227−243.
- Van Laake L, Hassink R, Doevendans P, Mummery C. Heart repair and stem cells. J Physiol 2006- 2: 467 478.
- Van de Werf, E.L.Topol, K.L.Lee and al. Variations in patient management for acute myocardial infarction in the United States and other countries. Results from the GUSTO Trial. JAMA 1995- 273: 1586−1591.
- Vinereanu D., Khokhar A., Fraser A.G. Reproducibility of pulsed wave tissue Doppler echocardiography. J Am Soc Echocardiogr 1999- 12: 492−499.
- Vulliet P.R., Greeley M., Halloran S.M., et al. Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004- 363: 783−784.
- Wagner G., Freye C., Palmari S. et al. The evaluation of a QRS scoring system for estimating myocardial infarct size. Circulation 1982- 65: 342 347.1. A? V A
- Wandt A., Bojo L., Tolagen E., Wranne A. Echocardiographic assessment of left ventricular ejection fraction in left ventricular hypertrophy. Heart 1999- 82: 192−198.
- Wang J.S., Shum-Tim D., Chedrawy E., Chiu R.C. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J. Thorac. Cardiovasc. Surg. 2001- 122 (4): 699−705.
- Wang J.S., Shum-Tim D., Galipeau J. et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 2000- 120 (5): 999−1005.
- Watanabe K., Wakabayashi H., Veerkamp J. et al. Immunohis-tochemical distribution of heart-type fatty acid-binding protein immunoreactivity in normal human tissues and in myocardial infarct. J Pathol 1993- 170: 59−65.
- Weaver W.D. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction. Eur. Heart J 1996- 17 (E): 14−20.
- Weaver W.D., Simes J.R., Betriu A., et al. Comparison of primary coronary angioplasty and Intravenous thrombolytic therapy for acute myocardial infection. JAMA 1997- 287: 2093−2098.
- Weisman H-F., Bush D.E., Mannisi J.A. et al. Cellular mechanisms of myoicardial infarction expansion. Circulation 1988- 78: 186−201.
- Wells R.G., Kong H., Blackwood K.J., et al. Towards myocardial stem cell therapy: tracking autologous mesenchymal bone marrow cells labeled with 111-In-tropolone in a canine model of myocardial infarction. J. Nucl. Med. 2004- V.45: 59 (Suppl).
- White H.D., Norris R.M., Brown M.A. et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987- 76(1): 44−51.
- Widimsky P., Budesinsky T., Vorac D. et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial PRAGUE-2. Eur Heart J 2003- 24: 94−104.
- Widimsky P., Budesinsky T., Vorac D. et al. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE-2. Eur Heart J 2003- 24: 94 104.
- Will K., Wodzig H. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann., Clin. Biochem. 1997- 34: 263 268.
- Williams DO, Braunwald E, Knatterud G. et al. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation 1992- 85: 533−542.
- Wollert K.C., Meyer G.P., Lotz J. et al. Randomized controlled clinical trial of intracoronary autologous bone marrow cell transfer post myocardial' infarction. Circulation 2003- 108: 108.
- Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after, myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004- 364(9429): 141 8.
- World Health Organisation criteria for the diagnosis of myocardial infarction. Geneva: WHO 1981.
- Wu A, Apple F., Gilber B, et al. National Academy of Clinical Biochemisty standarts of laboratory practice: recommendation for the use of cardiac marker in coronary artery disease. Clin Chem 1999- 45: 1104−1121.
- Wu A., Apple F., Gibler B. et al. Use of cardiac marker in coronary artery disease. 1998 NACB SOLP Recommendations. National meeting American Association of Clinical Chemistry. Chicago (Illinois) 1998.
- Xie Y, Zhou T., Shen W., et al. Soluble cell adhesion molecules in patients with acute coronary syndrome. Clin Med J. 2000: 113: 286−288.1. V V
- Yamada H., Oki O., Tabata O. et al. Assessment of left ventricular systolic wall motion velocity with pulsed tissue Doppler imaging: comparison withpeak dP/dt of the left ventricular pressure curve. J1 Am Soc Echocardiogr 1998- 11: 442−449.
- Yip H-K, Youssef AA, Chang L-T, et al. Association of Interleukin-10 Level With Increased 30-Day Mortality in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary. Coronary Intervention. Circ J'2007- 71: 1086−1091.
- Yoo K. J, Li R.K., Weisel R.D. et al. Autologous Smooth Muscle Cell Transplantation Improved Heart Function in Dilated Cardiomyopathy. Ann Thorac Surg. 2000- 70: 859 865.
- Yoon P.D.1, Kao R.L., Magovern G.J. Myocardial regeneration: transplanting satellite cells into damaged myocardium. Tex Heart Inst J 1995- 22: 119 25.
- Yoon Y.-S., Park J.-S., Tkebuchava T., et al. Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial' Infarction. Circulation 2004- 109: 3154 3157.
- Youn B. S, Mantel C., Broxmeyer H.E. Chemokines, chemokine receptors and hematopoiesis. Immunol Rev. 2000- 177: 150−174.
- Young A. C., Scapin G., Kromminga A. et al. Structural studies of human muscle fatty acid binding protein at 1.4 A resolution: binding interaction with theree C 18 fatty acids. Structure 1994- 2(6) :523−534.
- Zahn R., Schiele R., Seidl K. et al. Primary Angioplasty in Acute Myocardial Infarction: Differences Between Referred Patients and Those Treated in Hospitals with On-site Facilities? J Invasive Cardiol 1999- 11″: 213−219.
- Zannad F., Briancon S., Juillicrc Y. et al. Incidence, clinical and etiological- features, and outcomes of advanced chronic heart failure: the EPICAL study. J. Am. Coll. Cardiol. 1999- 33: 734−742.
- Zhang- S, Guo J, Zhang P. Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats. Life Sci. 2004- 74(23): 2853 2864.
- Zhu MM, Fcit A, Chadow H. ct al. Primary stent implantation compared with-primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J, Cardiol 2001- 88: 297−301.
- Zijlstra F, Bcukema WP, van’t Hof AW. et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy- in low risk patients with acute myocardial infarctiom JiAm Colli Cardiol 1997-:29: 908−912.
- Zijlstra F,.de Boer MJ, Hoorntje JC, Reiffers Si Rcibcr JH, Suryapranata H. A comparison^"of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction see comments. N Engl’J Med 1993- 328: 680 684.
- Zijlstra F, van’t Hof AW, Liem AL. et al. Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart 1997- 78: 333−336.
- Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998- 393: 595−599.
- Zymek P, Nah D-Y, Bujak M, et al. Interleukin-10 Is Not a Critical Regulator of Infarct Healing and Left Ventricular Remodeling. Cardiovasc Res. 2007- 74(2): 313−322.